title: Regulation of hypoxia inducible factor-1α expression by the alteration of redox status in HepG2 cells.
abstract: Hypoxia inducible factor-1 (HIF-1) has been considered as a critical transcriptional factor in response to hypoxia. It can increase P-glycoprotein (P-Gp) thus generating the resistant effect to chemotherapy. At present, the mechanism regulating HIF-1α is still not fully clear in hypoxic tumor cells. Intracellular redox status is closely correlated with hypoxic micro-environment, so we investigate whether alterations in the cellular redox status lead to the changes of HIF-1α expression. HepG2 cells were exposed to Buthionine sulphoximine (BSO) for 12 h prior to hypoxia treatment. The level of HIF-1α expression was measured by Western blot and immunocytochemistry assays. Reduce glutathione (GSH) concentrations in hypoxic cells were determined using glutathione reductase/5,5'-dithiobis-(2-nitrob-enzoic acid) (DTNB) recycling assay. To further confirm the effect of intracellular redox status on HIF-1α expression, N-acetylcysteine (NAC) was added to culture cells for 8 h before the hypoxia treatment. The levels of multidrug resistance gene-1 (MDR-1) and erythropoietin (EPO) mRNA targeted by HIF-1α in hypoxic cells were further determined with RT-PCR, and then the expression of P-Gp protein was observed by Western blotting. The results showed that BSO pretreatment down-regulated HIF-1α and the effect was concentration-dependent, on the other hand, the increases of intracellular GSH contents by NAC could partly elevate the levels of HIF-1α expression. The levels of P-Gp (MDR-1) and EPO were concomitant with the trend of HIF-1α expression. Therefore, our data indicate that the changes of redox status in hypoxic cells may regulate HIF-1α expression and provide valuable information on tumor chemotherapy.
authors: Teaching & Research Section of Nuclear Medicine, An-hui Medical University, Hefei, China. wensenjn@139.com
authors: Wen-sen
authors: WS
authors: Jin
authors: Zhao-lu
authors: ZL
authors: Kong
authors: Zhi-fen
authors: ZF
authors: Shen
authors: Yi-zun
authors: YZ
authors: Jin
authors: Wu-kui
authors: WK
authors: Zhang
authors: Guang-fu
authors: GF
authors: Chen
references: J Biol Chem. 1997 Sep 5;272(36):22642-7
references: 9278421
references: Proc Natl Acad Sci U S A. 2004 Mar 23;101(12):4302-7
references: 15010533
references: Cancer Res. 2002 Jun 15;62(12):3387-94
references: 12067980
references: Cardiovasc Hematol Agents Med Chem. 2006 Jul;4(3):189-97
references: 16842205
references: Cell Signal. 2002 Oct;14(10):799-810
references: 12135701
references: J Biol Chem. 2000 Jul 14;275(28):21130-9
references: 10801793
references: Free Radic Biol Med. 2005 Oct 1;39(7):925-36
references: 16140212
references: Mol Oncol. 2008 Jun;2(1):41-53
references: 19383328
references: Science. 2001 Nov 9;294(5545):1337-40
references: 11598268
references: Adv Enzymol Relat Areas Mol Biol. 1999;73:209-67, xii
references: 10218110
references: Cancer Lett. 2009 Apr 18;276(2):143-51
references: 19091459
references: Biochim Biophys Acta. 2007 Oct;1772(10):1175-81
references: 17964299
references: FASEB J. 2004 Feb;18(2):379-81
references: 14657004
references: J Biol Chem. 2007 Aug 17;282(33):23996-4003
references: 17573345
references: Eur Respir J. 2009 May;33(5):1195-205
references: 19407053
references: Mol Immunol. 2005 May;42(9):987-1014
references: 15829290
references: Mol Cell Biochem. 2008 Dec;319(1-2):163-74
references: 18690414
references: Nat Rev Cancer. 2003 Oct;3(10):721-32
references: 13130303
references: Proc Natl Acad Sci U S A. 1998 Sep 29;95(20):11715-20
references: 9751731
references: Toxicology. 2007 Jun 3;235(1-2):1-10
references: 17416446
references: Int J Cancer. 2007 Jan 15;120(2):268-77
references: 17066447
references: Free Radic Res. 2006 Aug;40(8):847-56
references: 17015263
references: Braz J Med Biol Res. 2002 Oct;35(10):1119-25
references: 12424482
references: Free Radic Biol Med. 2007 Oct 1;43(7):1061-75
references: 17761302
references: Toxicol In Vitro. 2008 Feb;22(1):28-35
references: 17728093
references: J Biol Chem. 2000 Aug 18;275(33):25733-41
references: 10823831
references: Blood. 2002 Mar 1;99(5):1552-5
references: 11861267
references: BJU Int. 2008 Feb;101(4):480-4
references: 17922867
references: Biol Pharm Bull. 2007 Nov;30(11):2181-4
references: 17978497
references: Cancer Biol Ther. 2008 Mar;7(3):468-75
references: 18285700
references: FASEB J. 2003 Mar;17(3):503-5
references: 12514119
references: J Androl. 2003 Sep-Oct;24(5):704-11
references: 12954661
references: J Immunol. 2008 Apr 1;180(7):4697-705
references: 18354193
references: Anticancer Res. 2009 Mar;29(3):797-807
references: 19414312
references: Cell Signal. 2002 Nov;14(11):879-97
references: 12220615
references: J Cell Sci. 2004 Jul 1;117(Pt 15):3201-6
references: 15199099
references: Hum Reprod. 2001 Nov;16(11):2422-6
references: 11679532
references: Biol Pharm Bull. 2008 Aug;31(8):1523-9
references: 18670083
references: Science. 2002 May 17;296(5571):1254-8
references: 12016299